Related Experiment Videos
The development of thrombolytic treatment in venous thrombosis. Experience with streptokinase-based regimens
VASA. Zeitschrift Fur Gefasskrankheiten
|January 1, 1986
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Unexpected bleeding following eyelid tumor resection leading to the rare diagnosis of acquired haemophilia.
Klinische Monatsblatter fur Augenheilkunde·2008
Quantification of coagulation factors and inhibitors. Still a special task.
Hamostaseologie·2006
[Heparins].
Therapeutische Umschau. Revue therapeutique·2003
[Factor XIII in man: a review].
Hamostaseologie·2002
Gingival bleeding, epistaxis and haematoma three days after gastroenteritis: the haemorrhagic lupus anticoagulant syndrome.
European journal of pediatrics·2001
Long-term clinical outcomes of self-expandable closed-cell and open-cell stents for endovascular reconstruction of the inferior vena cava.
VASA. Zeitschrift fur Gefasskrankheiten·2026
Atherectomy, scoring and drug-coated balloon angioplasty for atherosclerotic common femoral artery disease - A two center study.
VASA. Zeitschrift fur Gefasskrankheiten·2026
Mid-term results of orbital atherectomy in heavily calcified lesions above and below the knee.
VASA. Zeitschrift fur Gefasskrankheiten·2026
Hospital incidence, treatment and mortality of traumatic aortic injury in German hospitals.
VASA. Zeitschrift fur Gefasskrankheiten·2026
Vascular medicine in older adults - A call for structured cooperation to improve care.
VASA. Zeitschrift fur Gefasskrankheiten·2026
2-Year outcomes of endovascular therapy of popliteal artery restenosis.
VASA. Zeitschrift fur Gefasskrankheiten·2026
APOBEC3 Knockout in Lentiviral Packaging Cells Improves Therapeutic Transgene Sequence Fidelity.
Molecular therapy : the journal of the American Society of Gene Therapy·2026
PRDM16 as a Multifaceted Pharmacological Target in Kidney Diseases: From Epigenetic Mechanisms to Therapeutic Strategies.
Pharmaceuticals (Basel, Switzerland)·2026
Olmesartan-Loaded PLGA Nanoparticles Attenuate Methotrexate-Induced Kidney Injury: Association with the AT1R/ERK1/2 Signaling Axis.
Pharmaceuticals (Basel, Switzerland)·2026